Removal of the C6 vaccinia virus interferon-β inhibitor in the hepatitis C vaccine candidate MVA-HCV elicited in mice high immunogenicity in spite of reduced host gene expression
María Q. Marín(Consejo Superior de Investigaciones Científicas), Juan García‐Arriaza(Consejo Superior de Investigaciones Científicas)
Cited by 8
Related Papers
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1
|Journal of Antimicrobial Chemotherapy|2015|65